|
1
|
Sun Y, Zhang X, Xue X, Zhang Y, Xiao H and
Liang X: Rapid identification of polyphenol C-glycosides from
Swertia franchetiana by HPLC-ESI-MS-MS. J Chromatogr Sci.
47:190–196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pardo-Andreu GL, Paim BA, Castilho RF,
Velho JA, Delgado R, Vercesi AE and Oliveira HC: Mangifera indica
L. extract (Vimang) and its main polyphenol mangiferin prevent
mitochondrial oxidative stress in atherosclerosis-prone
hyper-cholesterolemic mouse. Pharmacol Res. 57:332–338. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pardo-Andreu GL, Dorta DJ, Delgado R,
Cavalheiro RA, Santos AC, Vercesi AE and Curti C: Vimang (Mangifera
indica L. extract) induces permeability transition in isolated
mitochondria, closely reproducing the effect of mangiferin,
Vimang's main component. Chem Biol Interact. 159:141–148. 2006.
View Article : Google Scholar
|
|
4
|
Daud NH, Aung CS, Hewavitharana AK,
Wilkinson AS, Pierson JT, Roberts-Thomson SJ, Shaw PN, Monteith GR,
Gidley MJ and Parat MO: Mango extracts and the mango component
mangiferin promote endothelial cell migration. J Agric Food Chem.
58:5181–5186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei ZQ, Yan L, Deng JG and Deng J:
Mangiferin protects rats against chronic bronchitis via regulating
NF-kappaB (P65) and IkappaBalpha expression in mononuclear cells.
Yao Xue Xue Bao. 49:596–601. 2014.In Chinese. PubMed/NCBI
|
|
6
|
Gong X, Zhang L, Jiang R, Ye M, Yin X and
Wan J: Anti-inflammatory effects of mangiferin on sepsis-induced
lung injury in mice via up-regulation of heme oxygenase-1. J Nutr
Biochem. 24:1173–1181. 2013. View Article : Google Scholar
|
|
7
|
Snoeck-Stroband JB, Lapperre TS, Gosman
MM, Boezen HM, Timens W, ten Hacken NH, Sont JK, Sterk PJ and
Hiemstra PS; Groningen Leiden Universities Corticosteroids in
Obstructive Lung Disease (GLUCOLD) Study Group: Chronic bronchitis
sub-phenotype within COPD: Inflammation in sputum and biopsies. Eur
Respir J. 31:70–77. 2008. View Article : Google Scholar
|
|
8
|
Marchant JM, Gibson PG, Grissell TV,
Timmins NL, Masters IB and Chang AB: Prospective assessment of
protracted bacterial bronchitis: Airway inflammation and innate
immune activation. Pediatr Pulmonol. 43:1092–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim KW, Jee HM, Park YH, Choi BS, Sohn MH
and Kim KE: Relationship between amphiregulin and airway
inflammation in children with asthma and eosinophilic bronchitis.
Chest. 136:805–810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Varin A and Gordon S: Alternative
activation of macrophages: Immune function and cellular biology.
Immunobiology. 214:630–641. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fong CH, Bebien M, Didierlaurent A,
Nebauer R, Hussell T, Broide D, Karin M and Lawrence T: An
antiinflammatory role for IKKbeta through the inhibition of
'classical' macrophage activation. J Exp Med. 205:1269–1276. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Classen A, Lloberas J and Celada A:
Macrophage activation: Classical versus alternative. Methods Mol
Biol. 531:29–43. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park KR and Bryers JD: Effect of
macrophage classical (M1) activation on implant-adherent macrophage
interactions with Staphylococcus epidermidis: A murine in vitro
model system. J Biomed Mater Res A. 100:2045–2053. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sunil VR, Patel-Vayas K, Shen J, Laskin JD
and Laskin DL: Classical and alternative macrophage activation in
the lung following ozone-induced oxidative stress. Toxicol Appl
Pharmacol. 263:195–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Draijer C, Robbe P, Boorsma CE, Hylkema MN
and Melgert BN: Characterization of macrophage phenotypes in three
murine models of house-dust-mite-induced asthma. Mediators Inflamm.
2013:6320492013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krausgruber T, Blazek K, Smallie T,
Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M and Udalova
IA: IRF5 promotes inflammatory macrophage polarization and TH1-TH17
responses. Nat Immunol. 12:231–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weiss M, Blazek K, Byrne AJ, Perocheau DP
and Udalova IA: IRF5 is a specific marker of inflammatory
macrophages in vivo. Mediators Inflamm. 2013:2458042013. View Article : Google Scholar
|
|
18
|
Wang M, Wang F, Yang J, Zhao D, Wang H,
Shao F, Wang W, Sun R, Ling M, Zhai J and Song S: Mannan-binding
lectin inhibits Candida albicans-induced cellular responses in
PMA-activated THP-1 cells through Toll-like receptor 2 and
Toll-like receptor 4. PLoS One. 8:e835172013. View Article : Google Scholar
|
|
19
|
Deng JG LXJ and Du ZC: A preparation
method of mangiferin. China: pp. 101973982013-2006-05.
|
|
20
|
Dai R, Gao J and Bi K: High-performance
liquid chromatographic method for the determination and
pharmacokinetic study of mangiferin in plasma of rats having taken
the traditional Chinese medicinal preparation Zi-Shen pill. J
Chromatogr Sci. 42:88–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Daigneault M, Preston JA, Marriott HM,
Whyte MK and Dockrell DH: The identification of markers of
macrophage differentiation in PMA-stimulated THP-1 cells and
monocyte-derived macrophages. PLoS One. 5:e86682010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Juhas U, Ryba-Stanislawowska M, Szargiej P
and Myśliwska J: Different pathways of macrophage activation and
polarization. Postepy Hig Med Dosw (Online). 69:496–502. 2015.
View Article : Google Scholar
|
|
23
|
García-Bermúdez M, López-Mejías R, Genre
F, et al: Interferon regulatory factor 5 genetic variants are
associated with cardiovascular disease in patients with rheumatoid
arthritis. Arthritis Res Ther. 16:R1462014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Menzies FM, Henriquez FL, Alexander J and
Roberts CW: Sequential expression of macrophage
anti-microbial/inflammatory and wound healing markers following
innate, alternative and classical activation. Clin Exp Immunol.
160:369–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chionh YT, Ng GZ, Ong L, Arulmuruganar A,
Stent A, Saeed MA, Wee JL and Sutton P: Protease-activated receptor
1 suppresses Helicobacter pylori gastritis via the inhibition of
macrophage cytokine secretion and interferon regulatory factor 5.
Mucosal Immunol. 8:68–79. 2015. View Article : Google Scholar
|
|
26
|
Ferrante CJ and Leibovich SJ: Regulation
of macrophage polarization and wound healing. Adv Wound Care (New
Rochelle). 1:10–16. 2012. View Article : Google Scholar
|
|
27
|
Yanagimachi M, Naruto T, Miyamae T, Hara
T, Kikuchi M, Hara R, Imagawa T, Mori M, Sato H, Goto H and Yokota
S: Association of IRF5 polymorphisms with susceptibility to
macrophage activation syndrome in patients with juvenile idiopathic
arthritis. J Rheumatol. 38:769–774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei Z, Yan L and Deng J and Deng J:
Effects of mangiferin on MAPK signaling pathway in chronic
inflammation. Zhongguo Zhong Yao Za Zhi. 36:1798–1802. 2011.In
Chinese. PubMed/NCBI
|
|
29
|
Márquez L, García-Bueno B, Madrigal JL and
Leza JC: Mangiferin decreases inflammation and oxidative damage in
rat brain after stress. Eur J Nutr. 51:729–739. 2012. View Article : Google Scholar
|
|
30
|
Li H, Huang J, Yang B, Xiang T, Yin X,
Peng W, Cheng W, Wan J, Luo F, Li H and Ren G: Mangiferin exerts
antitumor activity in breast cancer cells by regulating matrix
metalloproteinases, epithelial to mesenchymal transition, and
β-catenin signaling pathway. Toxicol Appl Pharmacol. 272:180–190.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bock C and Ternes W: The phenolic acids
from bacterial degradation of the mangiferin aglycone are
quantified in the feces of pigs after oral ingestion of an extract
of Cyclopia genistoides (honeybush tea). Nutr Res. 30:348–357.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lim J, Liu Z, Apontes P, Feng D, Pessin
JE, Sauve AA, Angeletti RH and Chi Y: Dual mode action of
mangiferin in mouse liver under high fat diet. PLoS One.
9:e901372014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rajendran P, Jayakumar T, Nishigaki I,
Ekambaram G, Nishigaki Y, Vetriselvi J and Sakthisekaran D:
Immunomodulatory effect of mangiferin in experimental animals with
benzo(a) pyrene-induced lung carcinogenesis. Int J Biomed Sci.
9:68–74. 2013.PubMed/NCBI
|
|
34
|
Menkovic N, Juranic Z, Stanojkovic T,
Raonic-Stevanovic T, Savikin K, Zdunić G and Borojevic N:
Radioprotective activity of Gentiana lutea extract and mangiferin.
Phytother Res. 24:1693–1696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Carvalho RR, Pellizzon CH, Justulin L Jr,
Felisbino SL, Vilegas W, Bruni F, Lopes-Ferreira M and Hiruma-Lima
CA: Effect of mangiferin on the development of periodontal disease:
Involvement of lipoxin A4, anti-chemotaxic action in leukocyte
rolling. Chem Biol Interact. 179:344–350. 2009. View Article : Google Scholar
|
|
36
|
Garrido G, González D, Lemus Y, Delporte C
and Delgado R: Protective effects of a standard extract of
Mangifera indica L. (VIMANG) against mouse ear edemas and its
inhibition of eicosanoid production in J774 murine macrophages.
Phytomedicine. 13:412–418. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Petrova A, Davids LM, Rautenbach F and
Marnewick JL: Photoprotection by honeybush extracts, hesperidin and
mangiferin against UVB-induced skin damage in SKH-1 mice. J
Photochem Photobiol B. 103:126–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kasbe P, Jangra A and Lahkar M: Mangiferin
ameliorates aluminium chloride-induced cognitive dysfunction via
alleviation of hippocampal oxido-nitrosative stress,
proinflammatory cytokines and acetylcholinesterase level. J Trace
Elem Med Biol. 31:107–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang B, Wan J, Gong X, Kuang G, Cheng X
and Min S: Mangiferin attenuates renal ischemia-reperfusion injury
by inhibiting inflammation and inducing adenosine production. Int
Immunopharmacol. 25:148–154. 2015. View Article : Google Scholar
|
|
40
|
Dou W, Zhang J, Ren G, Ding L, Sun A, Deng
C, Wu X, Wei X, Mani S and Wang Z: Mangiferin attenuates the
symptoms of dextran sulfate sodium-induced colitis in mice via
NF-κB and MAPK signaling inactivation. Int Immunopharmacol.
23:170–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
De A and Chattopadhyay S: The variation in
cytoplasmic distribution of mouse peritoneal macrophage during
phagocytosis modulated by mangiferin, an immunomodulator.
Immunobiology. 214:367–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yanagimachi M, Goto H, Miyamae T, Kadota
K, Imagawa T, Mori M, Sato H, Yanagisawa R, Kaneko T, Morita S, et
al: Association of IRF5 polymorphisms with susceptibility to
hemophagocytic lymphohistiocytosis in children. J Clin Immunol.
31:946–951. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang L, Chen B, Ma B and Nie S:
Association between IRF5 polymorphisms and autoimmune diseases: A
meta-analysis. Genet Mol Res. 13:4473–4485. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Clark DN, Lambert JP, Till RE, Argueta LB,
Greenhalgh KE, Henrie B, Bills T, Hawkley TF, Roznik MG, Sloan JM,
et al: Molecular effects of autoimmune-risk promoter polymorphisms
on expression, exon choice, and translational efficiency of
interferon regulatory factor 5. J Interferon Cytokine Res.
34:354–365. 2014. View Article : Google Scholar
|
|
45
|
Chua KH, Lian LH, Khor WC, Lee WS, Hilmi
I, Goh KL and Kee BP: Association between genetic polymorphisms in
interferon regulatory factor 5 (IRF5) gene and Malaysian patients
with Crohn's disease. J Dig Dis. 16:205–216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Feng D, Stone RC, Eloranta ML,
Sangster-Guity N, Nordmark G, Sigurdsson S, Wang C, Alm G, Syvänen
AC, Rönnblom L and Barnes BJ: Genetic variants and
disease-associated factors contribute to enhanced interferon
regulatory factor 5 expression in blood cells of patients with
systemic lupus erythematosus. Arthritis Rheum. 62:562–573.
2010.PubMed/NCBI
|
|
47
|
Balkhi MY, Fitzgerald KA and Pitha PM:
Functional regulation of MyD88-activated interferon regulatory
factor 5 by K63-linked polyubiquitination. Mol Cell Biol.
28:7296–7308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yasuda K, Nündel K, Watkins AA, Dhawan T,
Bonegio RG, Ubellacker JM, Marshak-Rothstein A and Rifkin IR:
Phenotype and function of B cells and dendritic cells from
interferon regulatory factor 5-deficient mice with and without a
mutation in DOCK2. Int Immunol. 25:295–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Steinhagen F, McFarland AP, Rodriguez LG,
Tewary P, Jarret A, Savan R and Klinman DM: IRF-5 and NF-κB p50
co-regulate IFN-β and IL-6 expression in TLR9-stimulated human
plasmacytoid dendritic cells. Eur J Immunol. 43:1896–1906. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Savitsky DA, Yanai H, Tamura T, Taniguchi
T and Honda K: Contribution of IRF5 in B cells to the development
of murine SLE-like disease through its transcriptional control of
the IgG2a locus. Proc Natl Acad Sci USA. 107:10154–10159. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mancl ME, Hu G, Sangster-Guity N,
Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, Pitha PM, Pinder K
and Barnes BJ: Two discrete promoters regulate the alternatively
spliced human interferon regulatory factor-5 isoforms. Multiple
isoforms with distinct cell type-specific expression, localization,
regulation, and function. J Biol Chem. 280:21078–21090. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Stone RC, Feng D, Deng J, Singh S, Yang L,
Fitzgerald-Bocarsly P, Eloranta ML, Rönnblom L and Barnes BJ:
Interferon regulatory factor 5 activation in monocytes of systemic
lupus erythematosus patients is triggered by circulating
autoantigens independent of type I interferons. Arthritis Rheum.
64:788–798. 2012. View Article : Google Scholar :
|
|
53
|
Mulens-Arias V, Rojas JM, Pérez-Yagüe S,
Morales MP and Barber DF: Polyethylenimine-coated SPIONs trigger
macrophage activation through TLR-4 signaling and ROS production
and modulate podosome dynamics. Biomaterials. 52:494–506. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Moreno-Fierros L, García-Hernández AL,
Ilhuicatzi-Alvarado D, Rivera-Santiago L, Torres-Martínez M,
Rubio-Infante N and Legorreta-Herrera M: Cry1Ac protoxin from
Bacillus thuringiensis promotes macrophage activation by
upregulating CD80 and CD86 and by inducing IL-6, MCP-1 and TNF-α
cytokines. Int Immunopharmacol. 17:1051–1066. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Byun MW: Schizonepeta tenuifolia ethanol
extract exerts anti-inflammatory activity through the inhibition of
TLR4 signaling in lipopolysaccharide-stimulated macrophage cells. J
Med Food. 17:350–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chanput W, Mes JJ, Savelkoul HF and
Wichers HJ: Characterization of polarized THP-1 macrophages and
polarizing ability of LPS and food compounds. Food Funct.
4:266–276. 2013. View Article : Google Scholar
|
|
57
|
Jeganathan S, Fiorino C, Naik U, Sun HS
and Harrison RE: Modulation of osteoclastogenesis with macrophage
M1- and M2-inducing stimuli. PLoS One. 9:e1044982014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jarvis JN, Meintjes G, Bicanic T, Buffa V,
Hogan L, Mo S, Tomlinson G, Kropf P, Noursadeghi M and Harrison TS:
Cerebrospinal fluid cytokine profiles predict risk of early
mortality and immune reconstitution inflammatory syndrome in
HIV-associated cryptococcal meningitis. PLoS Pathog.
11:e10047542015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Huang Y, Gao J, Meng XM, Jiang GL, Yang
YR, Li H, Liu J and Li J: Involvement of mitogen-activated protein
kinase activation in cyclooxygenase-2 and transforming growth
factor-β production in alveolar macrophage from chronic bronchitis
rats. Immunopharmacol Immunotoxicol. 33:645–651. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Dong L, Wang S, Chen M, Li H and Bi W: The
activation of macrophage and upregulation of CD40 costimulatory
molecule in lipopolysaccharide-induced acute lung injury. J Biomed
Biotechnol. 2008:8525712008. View Article : Google Scholar : PubMed/NCBI
|
